Diversity in clinical trials: It takes a village

Lorena Kuri; Cathy Florek; Jateh Major

Volume 32, Issue 3 - Artificial Intelligence and Machine Learning

Diversity in clinical trials: It takes a village

Authors: Lorena Kuri, Cathy Florek, Jateh Major

Abstract

Clinical trials are becoming more complex and the efforts to optimise drug development are rapidly evolving. This Q&A gives a short overview of the strategies Bristol Myers Squibb implements to incorporate diversity into the clinical trial development process with the intent to enhance equity and inclusion for the diverse patient community that uses the treatments we develop.

Medical Writing. 2023;32(3):74–75. https://doi.org/10.56012/ugmu9329

Download the full article

Volume 32, Issue 3 - Artificial Intelligence and Machine Learning

Diversity in clinical trials: It takes a village

Authors: Lorena Kuri, Cathy Florek, Jateh Major

Abstract

Search

Articles

Links

Editoral Board